PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.510
+0.035 (2.37%)
At close: Sep 22, 2026, 4:00 PM EDT
1.460
-0.050 (-3.31%)
After-hours: Sep 22, 2026, 7:58 PM EDT
PMV Pharmaceuticals Employees
PMV Pharmaceuticals had 54 employees as of December 31, 2025. The number of employees increased by 7 or 14.89% compared to the previous year.
Employees
54
Change (1Y)
7
Growth (1Y)
14.89%
Revenue / Employee
n/a
Profits / Employee
-$1,392,963
Market Cap
114.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 54 | 7 | 14.89% |
| Dec 31, 2024 | 47 | -16 | -25.40% |
| Dec 31, 2023 | 63 | 1 | 1.61% |
| Dec 31, 2022 | 62 | 8 | 14.81% |
| Dec 31, 2021 | 54 | 10 | 22.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| Vivani Medical | 42 |
| Cardiff Oncology | 31 |
| Genelux | 26 |
| Black Diamond Therapeutics | 21 |
| Tenax Therapeutics | 16 |
PMVP News
- 8 days ago - PMV Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 14 days ago - PMV Pharmaceuticals appoints Philip Herman as chief commercial officer - TheFly
- 22 days ago - PMV Pharmaceuticals 42M share Spot Secondary priced at $1.21 - TheFly
- 22 days ago - PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities - GlobeNewsWire
- 22 days ago - PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial - TheFly
- 22 days ago - PMV Pharmaceuticals announces common stock, warrants offering - TheFly
- 22 days ago - PMV Pharma Announces Proposed Public Offering of Securities - GlobeNewsWire
- 22 days ago - PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial - GlobeNewsWire